Activity not yet confirmed Verified 7 Nov 2026
PM Equity Partner (PMEP)
Lausanne-based corporate venture capital arm of Philip Morris International that makes minority investments, usually from Series A, in reduced-risk nicotine products, self-care and wellness, and sustainability technologies relevant to PMI.
- Type
- Corporate VC
- Location
- Lausanne, Switzerland
- Stages
- Series A, Series B, Growth
- Sectors
- Consumer, Healthtech and life sciences, Wellness, Climate and cleantech, Sustainability
- Fund size / AUM
- USD 350 million fund size (own site)
- Website
- www.pmequitypartner.com
Contacts on file
For PM Equity Partner (PMEP), the paid file holds: 3 named decision-makers with roles; firm contact email (domain checked); check size; how to pitch (the route the firm publishes); LinkedIn page.
Get Europe Complete, $99 Free sample
One-time payment. No subscription. No account.
Notable investments
NeuroMoodifyComet BioBiognosysTreatech
Sources
- www.pmequitypartner.com/
- www.pmequitypartner.com/about-us/
- www.pmequitypartner.com/backed-by-pmep/
- www.pmequitypartner.com/investment-focus/
- www.investeurope.eu/membership/member-search/
Last checked 7 Nov 2026. Is something wrong? Tell us.
Appears in 24 lists
Corporate venture capital firms in Europe (46)Series B consumer investors (59)Consumer investors in Europe (65)Corporate venture capital firms (84)Series B climate tech investors (98)Series B investors in Europe (117)Growth-stage consumer investors (124)Series A consumer investors (154)Series B healthtech investors (160)Growth-stage climate tech investors (189)Climate tech investors in Europe (250)Series A climate tech investors (263)Growth-stage investors in Europe (276)Healthtech investors in Europe (291)Growth-stage healthtech investors (316)Series A investors in Europe (329)Series B investors (339)Series A healthtech investors (401)Consumer investors (512)Climate tech investors (660)Growth-stage investors (705)Startup investors in Europe (725)Series A investors (864)Healthtech investors (1,207)